Thrombosis and blood vessel inflammation study
Part of Heart & circulation clinical trials.
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 5 years old
- You or your legal guardian can understand and sign a consent form
- You have a known or possible blood clotting, immune, or blood vessel disorder, or you are a relative of someone who does, or you are a healthy volunteer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at signs of “inflammation” (your body’s immune response) in people who are scheduled for vascular surgery. It may help researchers understand what’s happening in blood vessel disease and improve future care.
This study looks at healthy adults and how their blood vessels work. It may help researchers understand normal circulation so they can better compare changes in future conditions.
This study collects blood (and sometimes tissue samples) from people who may have vascular (blood vessel) problems and from certain pregnant participants. Researchers use the samples to better understand vascular disease and to help guide future research.
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
This study collects blood samples from people with various health conditions to help researchers develop and improve new diagnostic tests. If you have certain symptoms or conditions like blood clots, infections, heart problems, diabetes, or others, you may be able to take part.
This study looks at how the body stops bleeding or forms clots in people with bleeding or clotting disorders. It may help researchers understand these conditions better and improve evaluation tests.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.